In particular, IGF1R was localized at the plasma membrane in a higher percentage of both primary and recurrent/metastatic ACC compared to ACA (41/90 in primary ACC; 6/9 in recurrent or metastatic ACC and 3/17 in ACA, p < 0.05) (Fig. 1B). Here, IGF1R is linked to adrenal cortex carcinoma.